Togo vs Yemen: Treatment coverage for schistosomiasis
Togo
86.0%
in 2024
Yemen
78.7%
in 2022
Togo rank
6th
Yemen rank
9th
Treatment coverage for schistosomiasis over time
- Togo
- Yemen
How they compare
Togo currently reports 86.0% against 78.7% in Yemen, a difference of 7.3%.
That makes Togo's figure about 1.1 times Yemen's.
The two have swapped places 3 times across 12 shared years of data; in 2010 it was Togo ahead.
Togo ranks 6th and Yemen ranks 9th of 45 countries.
Across the 2 decades both report, Togo averaged higher in 1 and Yemen in 1.
Head to head by decade
| Decade | Togo | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 65.7% | 59.6% | 6.1% | Togo |
| 2020s | 38.4% | 67.6% | 29.2% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Togo or Yemen?
- Togo, at 86.0% against 78.7% in Yemen as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Togo and Yemen?
- 7.3%, with Togo ahead.
- How many years of comparable data are there for Togo and Yemen?
- 12 years are reported by both, from 2010 to 2022.
- How do Togo and Yemen rank globally for treatment coverage for schistosomiasis?
- Togo ranks 6th and Yemen ranks 9th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.